Contribution of bone marrow–derived endothelial cells to human tumor vasculature
Brock A. Peters(Complete Genomics (United States)), Christoph Lengauer(Blueprint Medicines (United States)), Joseph H. Antin(Dana-Farber Cancer Institute), Kathy Romans(Howard Hughes Medical Institute), Kenneth W. Kinzler(Johns Hopkins University), Eva C. Guinan(Dana-Farber Cancer Institute), Leslie Meszler(Sidney Kimmel Comprehensive Cancer Center), Bert Vogelstein(Johns Hopkins University), Stanley R. Hamilton(City of Hope), Kornélia Polyák(Dana-Farber Cancer Institute), David Myerson(University of Washington), Luis A. Díaz(Memorial Sloan Kettering Cancer Center)
Cited by 480
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Cancer Genome Landscapes
|Science|2013|8k